ArticleThe World Allergy Organization journal2020

Real-life effectiveness of mepolizumab in patients with severe refractory eosinophilic asthma and multiple comorbidities.

Claudia Crimi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.